Identifying the Risk Factors for Mortality in Patients with Cancer and COVID-19 in Hamadan, the West of Iran

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  M. Dieci,et al.  Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study , 2021, European journal of cancer.

[3]  M. Dieci,et al.  Epidemiology and clinical course of SARS-CoV-2 infection in cancer patients in the Veneto Oncology Network: The ROVID Study , 2021, European Journal of Cancer.

[4]  Patrick W. Johnson,et al.  Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 , 2021, The New England journal of medicine.

[5]  A. Kasaeian,et al.  Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study , 2020, Infectious Agents and Cancer.

[6]  K. Bhaskaran,et al.  Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data , 2020, EClinicalMedicine.

[7]  Á. Avezum,et al.  Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. , 2020, JAMA.

[8]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[9]  V. Torri,et al.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study , 2020, The Lancet Oncology.

[10]  D. Ma,et al.  Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis , 2020, Journal of Hematology & Oncology.

[11]  L. Paz-Ares,et al.  SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death , 2020, European Journal of Cancer.

[12]  F. Goldwasser,et al.  Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone but decide wisely , 2020, European Journal of Cancer.

[13]  Zhiquan Hu,et al.  Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study , 2020, The Lancet Oncology.

[14]  D. Kerr,et al.  COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study , 2020, The Lancet.

[15]  M. Luppi,et al.  Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! , 2020, European Journal of Cancer.

[16]  H. Miyashita,et al.  Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City , 2020, Annals of Oncology.

[17]  Qiongjing Yuan,et al.  The epidemiology and clinical information about COVID-19 , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[19]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[20]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[21]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[22]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[23]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[24]  T. H. Hieu,et al.  Incidence of Infection-related mortality in cancer patients: Trend and survival analysis. , 2019, Journal of Clinical Oncology.

[25]  A. Meert,et al.  Acute respiratory distress syndrome in patients with malignancies , 2014, Intensive Care Medicine.

[26]  E. Bow.  There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy. , 2013, The Journal of antimicrobial chemotherapy.

[27]  S. Chevret,et al.  Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. , 2010, American journal of respiratory and critical care medicine.